References
- Linares M, Solis F, Casal M. In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of Sensititre and NCCLS M27-A2 methods of detection. J Clin Microbiol 2005; 43: 2520–2522.
- Pore SE, Barnett E, Barnes W, Walker J. Prototheca ecology. Mycopathologia 1983; 81: 49–62.
- Nelson A, Neafie R, Connor D. Cutaneous protothecosis and chlorellosis, extraordinary “aquatic borne” algal infections. Clin Dermatol 1987; 5: 76–87.
- Leimann B, Monteiro P, Lazera M, Candanoza E, Wanke B. Protothecosis. Med Mycol 2004; 42: 106–
- Lass-Flörl C, Mayr A. Human Protothecosis. Clin Microbiol Rev 2007; 20: 230–242.
- Phair J, Williams J, Bassaris H, Zeiss C, Morlock B. Phagocytosis and algicidal activity of human polymorphonuclear neutrophils against Prototheca wickerhamii. J Infect Dis 1981; 144: 72–77.
- Torres HA, Bodey GP, Tarrand JJ, Kontoyiannis DP. Protothecosis in patients with cancer: case series and literature review. Clin Microbiol Infect 2003; 9: 786–792.
- Padhye A, Baker J, D’Amato F. Rapid identification of Prototheca species by the API 20C system. J Clin Microbiol 1979; 52: 527–531.
- Kapica L. First case of human protothecosis in Canada: laboratory aspects. Mycopathologia 1981; 73: 43–48.
- Shahan T, Pore S. In vitro susceptibility of Prototheca spp. to gentamicin. Antimicrob Agents Chemother 1991; 35: 2434–2435.
- Segal E, Padhyde A, AjelloL. Susceptibility of Prototheca species to antifungal agents. Antimicrob Agents Chemother 10: 75—79..
- Sands M, Poppel D, Brown R. Peritonitis due to Prototheca wickerhamii in a patient undergoing chronic ambulatory peritoneal dialysis. Rev Infect Dis 1991; 13: 376–378.
- Sheikh-Ahmad M, Goldstein S, Potasman I. Prototheca wickerhamii hand infection successfully treated by itraconazole and voriconazole. J Travel Med 2006; 13: 321–323.